CURRENT FUNDING OPPORTUNITIES IN APPLIED NEUROSCIENCE AND PSYCHOPHYSIOLOGY

Department of Defense
Dept. of the Army -- USAMRAA
U.S. Army Medical Research and Material Command Broad Agency Announcement for Extramural Medical Research
Grant
http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=58236

Click on "Full Announcement" at the top of the page.  Then click on the "U.S. Army Medical Research and Material Command Broad Agency Announcement for Extramural Medical Research".  A listing of specific research topics begin on page 3 of this document.

The deadline is Sept. 30, 2011.

--------------------------------------------------------------------- 

Title:Fellowship Awards in the Neurosciences

Sponsor:          Klingenstein (Esther A. & Joseph) Fund

SYNOPSIS:   The purpose of these awards is to support, in the early stages of their careers, young investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders.

Deadline:  01/07/2011
Established Date: 09/24/1984
Follow-Up Date: 11/01/2011
Review Date: 09/28/2010

Contact:          Ms. Kathleen Pomerantz, Vice President                                                             

Address: 787 Seventh Avenue,6th Floor, New York, NY 10019-6016
E-mail: kathleen.pomerantz@klingenstein.com
Web Site: http://www.klingfund.org/
Program URL: http://www.klingfund.org/apply.php
Tel: 212-492-6181 
Deadline Ind: Receipt 
Deadline Open:No
*See Restrictions for further information. 

DEADLINE NOTE
Applications must be received by January 7, 2011; awards will be
announced in the Spring of 2011, to commence on July 1, 2011.

Award Type(s): Fellowship

Citizenship/Country of Applying Institution:

Any/No Restrictions
U.S.A. Citizenship (including U.S. Territories)
U.S. Permanent Resident

Locations Tenable:U.S.A. Institution (including U.S. Territories)

Appl Type(s): Postdoctoral, Physician/Medical Professional, Young Investigator/Junior Faculty

Target Group(s):  NONE
Funding Limit: $150,000  
Duration: 3 YEAR(s)
Indirect Costs:   No
Cost Sharing:     No
Sponsor Type: Memorial/Individual Funds

OBJECTIVES:   The sponsor realizes that to achieve its purpose it is necessary to encourage a variety of new approaches. Several areas within the neurosciences are of particular interest to the sponsor:  Cellular and molecular neuroscience—Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior.  Neural systems Studies of the integrative function of the nervous system.  Clinical research—Studies designed to improve the prevention, diagnosis, treatment and our understanding of the causes of neurological and psychiatric disorders. 

ELIGIBILITY

To qualify for an award investigators must hold Ph.D. and/or M.D. degrees, and have completed all research training, including post-doctoral training. Applications will be reviewed, and selections made by an Advisory Committee of distinguished neuroscientists.  U.S. citizenship is not a requirement, but it is expected that candidates
will be permanent residents of the U.S. and that their research will be carried out in U.S. institutions. Holding an award from another foundation concurrently with a Klingenstein award requires the approval of the Advisory Committee. The candidate should be an
independent investigator, holding a tenure track academic rank (but not yet tenured) in a university or medical school, or the equivalent standing in a research institute or medical center.

FUNDING
The award of $150,000 is payable over a three-year period. It may be used for salary support, research assistants, equipment, or for any other purpose that promotes the scientific activities of the Klingenstein Fellow. The award is for the exclusive use of the Fellow and may not be used for institutional or departmental support. No provision is made for institutional overhead, but fringe benefits maybe charged to the award. Payments will be made to the investigator's institution with the understanding that the total amount of the award is to be made available to the Klingenstein Fellow, and will be
transferred (together with any purchased equipment) should the Fellow change institutions. Annual reviews of the Fellow's activities and the funds disbursed will be required. (flb)

KEYWORDS:
Brain

Nervous System
Biomedical Research,

Multidisciplinary

Molecular/Cellular Entities
Cellular Biology
 Molecular Biology
 Neuroscience
Mental Disorders/Illness

TITLE:
Clinically Relevant Comparative Effectiveness of Alcoholism Treatments (R01)
FON: PAS-10-273
AGENCY:
U.S. Department of Health and Human Services; National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism
ITEM:
Notice seeking applications to support research on the comparative effectiveness in typical clinical settings of pharmacologic and behavioral treatments for alcohol use disorders given patient characteristics, and the organizational, financial, and management factors that facilitate or inhibit the delivery of evidence-based services for alcohol use disorders.
ACTION:
Applications are due annually by February 5, June 5, and October 5. Approximately $1.5 million is available to support up to six awards. Colleges and universities are eligible to apply.
LINKS:
Solicitation http://grants.nih.gov/grants/guide/pa-files/PAS-10-273.html, Grants.gov notice http://www.grants.gov/search/search.do?mode=VIEW&oppId=56885

CONTACT:
Cherry Lowman, 301/443-0637. Fax: 301/443-3891. E-mail: clowman@mail.nih.gov.

___________________

TITLE:
Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes
FON:
PA-10-255 (R01)
PA-10-256 (R21)
AGENCY:
U.S. Department of Health and Human Services; National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism
ITEM:
Notice seeking applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence.
ACTION:
R01: Applications are due by February 5, June 5, and October 5 annually. R21: Applications are due by February 16, June 16, and October 16 annually. Colleges and universities are eligible to apply.
LINKS:
PA-10-255:
Solicitation http://grants.nih.gov/grants/guide/pa-files/PA-10-255.html, Grants.gov notice http://www07.grants.gov/search/search.do?mode=VIEW&oppId=56502

PA-10-256:
Solicitation
http://grants.nih.gov/grants/guide/pa-files/PA-10-256.html, Grants.gov notice http://www07.grants.gov/search/search.do?mode=VIEW&oppId=56503

CONTACT:
Ivana Grakalic, 301/443-7600. Fax: 301/443-1650. E-mail:
igrakalic@mail.nih.gov

_____________________________________________________

Basic Research on Self-Regulation (R21)
(RFA-AG-11-010)
Application Receipt Date(s): January 06, 2011
http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-11-010.html


Executive Summary

* Purpose. This FOA issued by the NIH Basic Behavioral and Social Sciences Opportunity Network (OppNet) solicits exploratory/developmental (R21) research applications examining basic mechanisms of self-regulation.  The intent of this FOA is to advance research on basic processes and mechanisms of self-regulation, capitalizing on recent advances in methods and theory from the psychological (social, personality, developmental), economic, neuroscience, sociocultural, and other behavioral and social science literatures. The current lack of consistency and conceptual integration in how self-regulation is studied across a range of disciplines hinders our understanding of the basic mechanisms underlying many important health and developmental outcomes.  Applications submitted to this FOA are expected to address one or more of the following basic behavioral and social science research (b-BSSR) challenges: (1) to precisely identify and operationally reconcile the basic processes and mechanisms involved in self-regulation of cognition, emotion, and behavior, and refine their measurement and theoretical conceptualizations, (2) to assess relations among various self-regulatory functions and their sub-components, and (3) to systematically characterize changes in self-regulatory functions over time, across different social and environmental contexts, and across the lifespan in both men and women. Proposals are expected to engage investigators working at multiple levels of analysis and across disparate literatures.

    * Mechanism of Support. This FOA will utilize the R21 award mechanism.
    * Funds Available and Anticipated Number of Awards. OppNet intends to commit approximately $1,900,000 in total costs (Direct plus Facilities and Administrative (F&A) costs) in FY 2011 to fund 6-8 new grants in response to this FOA.
    * Budget and Project Period. The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.
    * Application Research Strategy Length: The R21 Research Strategy section may not exceed 6 pages, including tables, graphs, figures, diagrams, and charts. See http://grants1.nih.gov/grants/funding/funding_program.htm,
    * Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.
    * Eligible Project Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/ organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
    * Number of PDs/PIs. More than one PD/PI (i.e., multiple PDs/PIs) may be designated on the application.
    * Number of Applications. Applicants may submit more than one application, provided each application is scientifically distinct.
    * Resubmissions.    Resubmission applications are not permitted in response to this FOA.
    * Renewals. Renewal applications are not permitted in response to this FOA.
    * Special Date(s). This FOA uses non-standard due dates. See Receipt, Review and Anticipated Start Dates.
    * Application Materials. See Section IV.1 for application materials.
    * General Information. For general information on SF424 (R&R) Application and Electronic Submission, see these Web sites:
SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm
General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/

_____________________

TITLE:
Research on Autism and Autism Spectrum Disorders

FON:
PA-10-158 (R01)
PA-10-159 (R03)
PA-10-160 (R21)

AGENCY:
U.S. Department of Health and Human Services (HHS); National Institutes
of Health (NIH); Multiple Institutes

ITEM:
Notice seeking applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD).

ACTION:
R01: Applications are due by February 5, June 5, and October 5 annually.
R03 and R21: Applications are due by February 16, June 16, and October
16 annually. Colleges and universities are eligible to apply.

LINKS:
PA-10-158:
Solicitation http://grants.nih.gov/grants/guide/pa-files/PA-10-158.html,

PA-10-159: Solicitation
http://grants.nih.gov/grants/guide/pa-files/PA-10-159.html,

PA-10-160:
Solicitation
http://grants.nih.gov/grants/guide/pa-files/PA-10-160.html,

CONTACT:
Varies by institute.

Mechanisms Underlying the Links between Psychosocial Stress, Aging, the Brain and the Body (R01)
(PA-09-216)
National Institute on Aging
National Cancer Institute
National Institute of Mental Health
Application Receipt/Submission Date(s): Multiple dates, see announcement.
http://grants.nih.gov/grants/guide/pa-files/PA-09-216.html

Executive Summary

* Purpose. This FOA encourages multidisciplinary and interdisciplinary research to elucidate the mechanistic links between psychosocial stress and health in aging, as well as how the aging process and age-related diseases affect the responses to psychosocial stressors.  Generally, research should be focused on (1) aging and how neural mechanisms respond to psychosocial stress and affect other body systems, (2) characterizing the behavioral, psychological and social mechanisms and pathways involved in transducing psychosocial stressors into health outcomes, (3) how stressors modulate physiological process underlying life-span, immune mechanisms, and metabolism, and (4) how psychosocial stress contributes to the development or progression of geriatric syndromes, chronic medical conditions, and disabilities in later life. Research is strongly encouraged that aims to identify appropriate targets for intervention, at any level of analysis, from societal to molecular.  Research spanning multiple levels of analysis is particularly encouraged. Research focused on oxidative stress or on environmental or physical stressors of a non-psychosocial nature is not appropriate to this FOA.    
    * Mechanism of Support. This FOA will utilize the R01 grant mechanism.
    * Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
    * Budget and Project Period. The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. Because the nature and scope of the proposed research will vary from 

application to application, it is anticipated that the size and duration of each award will also vary. 
    * Application Research Plan Component Length: The R01 application Research Plan component of the PHS398 may not exceed 25 pages, including tables, graphs, figures, diagrams, and charts. See http://grants1.nih.gov/grants/funding/funding_program.htm
    * Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.
    * Eligible Project Directors/Principal Investigators (PDs/PIs). Include Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
    * Number of PDs/PIs. More than one PD/PI (i.e., multiple PDs/PIs), may be designated on the application.
    * Number of Applications. Applicants may submit more than one application, provided that each application is scientifically distinct.
    * Resubmissions. Applicants may submit a resubmission application, but such application must include an 

Introduction addressing the previous peer review critique (Summary Statement). See new NIH policy on resubmission (amended) applications (NOT-OD-09-003, NOT-OD-09-016).
    * Renewals: Applicants may submit a renewal application.
    * Application Materials. See Section IV.1 for application materials.
    * General Information. For general information on SF424 (R&R) Application and Electronic Submission, 

see these Web sites:
SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm
General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/

http://grants.nih.gov/grants/guide/pa-files/PAR-10-163.html

Title: Preliminary Clinical Studies in Preparation for Large

Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34)

Announcement Type

New

Program Announcement (PAR) Number: PAR-10-163

NOTICE: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be

submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and

the SF424 (R&R) Application Guide.

APPLICATIONS MAY NOT BE SUBMITTED IN PAPER FORMAT.

This FOA must be read in conjunction with the application guidelines included with this announcement in Grants.gov/Apply for

Grants (hereafter called Grants.gov/Apply).

A registration process is necessary before submission and applicants are highly encouraged to start the process at least four (4)

weeks prior to the grant submission date. See Section IV.

A compatible version of Adobe Reader is required for download. For Assistance downloading this or any Grants.gov application

package, please contact Grants.gov Customer Support at http://grants.gov/CustomerSupport.

Catalog of Federal Domestic Assistance Number(s)

93.213

Key Dates

Release/Posted Date: April 6, 2010

Opening Date: September 16, 2010 (Earliest date an application may be submitted to Grants.gov)

Letters of Intent Receipt Date(s): Not required

NOTE: On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m.

local time (of the applicant institution/organization).

Application Due Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm

AIDS Application Due Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#AIDS.

Peer Review Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward

Council Review Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward

Earliest Anticipated Start Date(s): Standard dates apply, please see http://grants1.nih.gov/grants/funding/submissionschedule.htm#reviewandaward

Additional Information To Be Available Date (URL Activation Date): Not Applicable

Expiration Date: September 8, 2013

Due Dates for E.O. 12372

PAR-10-163: Preliminary Clinical Studies in Preparation for Large Interv. http://grants.nih.gov/grants/guide/pa-files/PAR-10-163.html

1 of 21 7/16/2010 7:14 PM

Not Applicable

Additional Overview Content

Executive Summary

Purpose. The goal of this FOA, issued by the National Center for Complementary and Alternative 

Medicine, is to support early phase clinical research and development on high priority CAM 

interventions. This mechanism is intended to support the development of methodology and 

the preliminary data needed for planning and design of subsequent, larger randomized clinical 

trials, cluster randomized trials or cohort studies. This mechanism is not appropriate for support

of randomized clinical trials to test or determine efficacy. It is appropriate for development

of preliminary studies that will contribute to the design of either efficacy or real-world effectiveness studies.

Mechanism of Support. This FOA will utilize the R34 grant mechanism.

Funds Available and Anticipated Number of Awards. Awards issued under this FOA are c

ontingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Budget and Project Period. The total project period for an application submitted in response to this FOA 

cannot exceed three years. Applicants may request up to $100,000 in direct costs for the initial administrative 

period (up to 12 months) of the award, with an annual limit of $225,000 in direct costs for any year of the 

project. This R34 is limited to direct cost requests of up to $450,000 over the entire project period. 

Although variations from year to year are permissible, in no case may any year be more than $225,000 in direct costs.

Application Research Strategy Length: The R34 Research Strategy section may not exceed 12 pages, 

including tables, graphs, figures, diagrams, and charts. See Table of Page Limits.

Eligible Institutions/Organizations. Institutions/organizations listed in Section III, 1.A. are eligible to apply.

Eligible Project Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and

resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities

are always encouraged to apply for NIH support.

Number of PDs/PIs. More than one PD/PI (i.e., multiple PDs/PIs) may be designated on the application.

Number of Applications. Applicants may submit more than one application, provided that each application is scientifically distinct.

Resubmissions. Applicants may submit a resubmission application, but such application must include an Introduction a

ddressing the previous peer review critique (Summary Statement). See new NIH policy on resubmission (amended) applications (NOT-OD-09-003, NOT-OD-09-016).

Renewals. Applicants may not submit a renewal application.

Application Materials. See Section IV.1 for application materials.

General Information. For general information on SF424 (R&R) Application and Electronic Submission, see these Web sites:

SF424 (R&R) Application and Electronic Submission Information: http://grants.nih.gov/grants/funding/424/index.htm

General information on Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/

Hearing Impaired. Telecommunications for the hearing impaired are available at: TTY: (301) 451-5936

________________________

2011 McKnight Scholar Awards

September 2010

PLEASE NOTE: THE DEADLINE FOR THE 2011 MCKNIGHT SCHOLAR AWARDS IS MONDAY, JANUARY 10, 2011.

The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain and behavior can be accurately diagnosed, prevented, and treated. To this end, the McKnight Endowment Fund for Neuroscience invites applications for the 2011 McKnight Scholar Awards.

These awards were established to encourage emerging neuroscientists to focus on disorders of learning and memory. Applicants for the McKnight Scholar Awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience. Awards are given to exceptional young scientists who hold the M.D. and/or Ph.D. degree and who are in the early stages of establishing an independent laboratory and research career. Traditionally, successful candidates have held faculty positions for at least one year. A list of previous recipients and their projects is available here.

Up to six McKnight Scholars each will receive three years of support, beginning July 1, 2011.

Eligibility. Applicants must have the following:

PLEASE NOTE: APPLICANTS MUST BE IN A TENURE-TRACK POSITION; RESEARCH FACULTY WITH ANNUALLY RENEWABLE CONTRACTS ARE NOT ELIGIBLE.

Applicants may not:

Amount and Purpose of Support. Each McKnight Scholar will receive $75,000 annually in 2011, 2012 and 2013. Funds may be used in any way that will facilitate development of the Scholar's research program, but not for indirect costs.

Selection Process. A review committee will evaluate applications and invite a select few to interview with the committee. Applicants selected will be notified by March 26, 2011. The interviews are scheduled for Friday, April 29, 2011, in San Francisco. The committee will then recommend candidates to the Board of Directors of the Endowment Fund for final decision. Awards will be announced on or before May 20, 2011.

Filing of Scholar Award Application. Please email one PDF of the completed application to emaler@mcknight.org (references will be submitted separately). If you do not receive confirmation of receipt within a week of submission, please call Eileen at 612-333-4220.

Download application and guidelines.

Completed applications must arrive no later than January 10, 2011

Last updated CRK Oct 15, 2010

International Society for Neurofeedback & Research

Executive Director, P.O. Box 6912, Corpus Christi, TX 78466 - (800) 488-3867
Membership & Conference Coordinator, 14493 S. Padre Island Drive Suite A, PMB 257, Corpus Christi, TX 78418 - (800) 847-4986